We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-12.50 | -2.79% | 435.00 | 430.00 | 445.00 | 447.50 | 437.50 | 447.50 | 32,309 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 46.49 | 207.38M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/3/2017 18:06 | Agree. Regards,Source. | source | |
06/3/2017 17:56 | It feels suspiciously like a bid, but I sincerely hope that it is not. There is a lot of potential with this company, even ignoring North America. The chairman has a lot of shares - and I hope that he keeps them at this stage in the company's evolution. Predators are bound to be circling, but it would be very annoying if they picked it up relatively on the cheap. | james188 | |
06/3/2017 17:24 | Good question vetpeter2. Can't believe it's just down to IC update. I'm intrigued but in any event imho I think this company is bound to get a takeover approach from the States particularly once they get regulatory approval to sell over there. Seen this happen a few times before with niche operators like this. A big company lets them do all the hard work getting the necessary approvals and then pounces. | gre | |
06/3/2017 16:31 | TSTL up 11% today. Why? | vetpeter2 | |
03/3/2017 18:58 | Tip Update in IC | cyfran101 | |
27/2/2017 08:02 | Icing on the cake Must be options time and well done :-) | piedro | |
23/2/2017 18:08 | The results webinar is here: | santar | |
23/2/2017 14:14 | Process of approvals from FDA and EPA in US making very good progress. The chemistry is not new to them completely but some areas are novel, such as endoscope sterilisation also surface cleaning and diagnostic instrument cleaning. TSTL advantage is speed, cuts down waiting time between patients. Patent protected packaging solutions ensure freshness as chlorine dioxide is produced on demand from two individual chemicals. This is the "moat" around Tstl with 15 years of development behind it. If you are new to TSTL, do read back a year on this thread, some good research to understand the basics. Webinar on Equity Development website later. | melton john | |
23/2/2017 12:47 | Good update and shows in the share price Big growth in Germany, will this be affected later by Brexit I wonder. Glad I topped up a bit two weeks ago! | trapperjez | |
23/2/2017 10:04 | StockMarketWire.com - Tristel has more than tripled its H1 pretax profit to £1.7m, from a profit of £0.46m. Revenue was £9.7m, from £8.0m. All on North America. | petewy | |
17/2/2017 14:37 | I sold a non performer last week and put half in Tstl. Still bullish and ready for a good update. Not expecting fireworks yet but no reason to be pessimistic. | melton john | |
16/2/2017 23:03 | Fingers x;d for next weeks result. Might get an update on the USA too. Some way below its peak around November so some growth in the share price should come about if results are good. | mach100 | |
15/2/2017 11:14 | Another way to kill superbugs discovered? Regards, Source. | source | |
31/1/2017 16:52 | finally in the news ... 26 January, 2017 By Kate Sweeney Tristel top of the class after French study Tristel plc, the AIM-quoted manufacturer of infection prevention, contamination control and hygiene products, is basking in the outcome of a major study. ... | piedro | |
26/1/2017 11:46 | There will be an interim results webinar on Thursday 23rd of February at 12:15 pm You can register with Equity Development and send in any questions. We get the first innings, followed by the investor presentations @ 13:45 and 17:00 pm {as per RNS} | piedro | |
18/1/2017 09:48 | Very pleasantly surprised to see a rise today post May's speech. Some big trades, possibly people being optimistic about new trade deals post Europe. Years ago we traded with the world not just mainly Europe, bring it on. | melton john | |
15/1/2017 10:37 | Awareness & concerns of superbugs still Rife (this one from the USA) Regards, Source hxxps://www.technolo A Woman in Nevada Died from an Unstoppable Superbug Her death is a reminder that antibiotic-resistant bacteria are getting worse, even as they garner little attention. by Michael Reilly January 13, 2017 | source | |
09/1/2017 16:14 | Money Observer Richard Beddards 5 Tips hxxp://www.moneyobse | martinthebrave | |
06/1/2017 20:56 | Good luck RCT2 ;) | melton john | |
05/1/2017 10:56 | MJ, I'm a specialist in selling too soon, so good luck to all who remain. I will certainly be back here if the price falls back, as I have a high regard for the company and they are a good company in a good sector. | rcturner2 | |
05/1/2017 10:25 | as some people are taking profits and looking elsewhere maybe it's time for a reminder of what we're about, namely fighting the rise of antibiotics resistant infections. | melton john | |
04/1/2017 16:19 | Full page in CJS November 2016 | piedro | |
04/1/2017 08:52 | "he thinks". I think this is a keeper and I won't be taking short term profit like you did. Shares like Tstl can run away very quickly and I don't want to put my money somewhere else or just take it off the table and miss an announcement. Each to their own. | melton john | |
31/12/2016 15:13 | Source, has Simon Thompson in the IC not recommended a sell on this? Mainly because he thinks it has reached full value? | rcturner2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions